STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Issuer (INSP) files Form 144 for planned sale of 2,000 common shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of the issuer filed a Form 144 notice to sell 2,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate aggregate market value of $254,660. The filing lists total shares of this class outstanding as 29,056,434.

The shares to be sold were acquired on 03/17/2023 by exercising stock options granted by the issuer, with the purchase price paid in cash on the same date. This notice reflects a planned sale by or for the account of a person related to the issuer under Rule 144, and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the INSP Form 144 filing disclose?

The filing discloses that an affiliate of the issuer intends to sell 2,000 shares of common stock on the NYSE under Rule 144, with an approximate aggregate market value of $254,660.

How many INSP shares are being sold and through which broker?

The notice covers a proposed sale of 2,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, to be executed on the NYSE.

When were the INSP shares being sold under Rule 144 originally acquired?

The 2,000 shares were acquired on 03/17/2023 via previously exercised stock options from the issuer, with the purchase price paid in cash on that date.

What is the aggregate market value and share count context for this INSP sale?

The proposed sale has an approximate aggregate market value of $254,660, and the filing lists 29,056,434 shares of this class of common stock as outstanding.

On what date is the INSP Rule 144 sale expected to occur?

The filing indicates an approximate sale date of 11/28/2025 for the 2,000 shares of common stock on the NYSE.

What representation does the seller make in the INSP Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

3.89B
28.71M
1.14%
117.62%
7.94%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY